Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE ( (Q57396224)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (	article

Statements

scholarly article

0 references

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE ( (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systolic heart failure

1 reference

based on heuristic

inferred from title

object named as

John J.V. McMurray

6

0 references

5

object named as

Lars Kober

0 references

1

object named as

Henry Krum

0 references

Kenneth Dickstein

4

object named as

Kenneth Dickstein

0 references

William T Abraham

3

object named as

William T. Abraham

0 references

Claudio R Gimpelewicz

8

object named as

Claudio Gimpelewicz

0 references

Barry M. Massie

2

object named as

Barry Massie

0 references

Bernard Reimund

10

object named as

Bernard Reimund

0 references

author name string

Ashkay Desai

7

0 references

Albert Kandra

9

0 references

Henning Rattunde

11

0 references

Juergen Armbrecht

12

0 references

publication date

January 2011

0 references

European Journal of Heart Failure

0 references

13

0 references

107-114

0 references

1

0 references

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Current concepts in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

A graphical approach to sequentially rejective multiple test procedures

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

BNP and congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ212

21 January 2018

Identifiers

10.1093/EURJHF/HFQ212

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57396224&oldid=1744703530"